Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation.

Saved in:
Bibliographic Details
Title: Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validation.
Authors: Tsai YC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan.; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica Taipei 110, Taiwan., Huang SP; Department of Urology, Kaohsiung Medical University Hospital Kaohsiung 807, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.; Ph.D. Program in Environmental and Occupational Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.; Institute of Medical Science and Technology, College of Medicine, National Sun Yat-Sen University Kaohsiung 804, Taiwan., Cheng WC; Ph.D. Program for Cancer Biology and Drug Discovery, Cancer Biology and Precision Therapeutics Center, China Medical University Taichung 404, Taiwan., Fan YC; Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica Taipei 110, Taiwan., Lin YC; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan., Tsai SY; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University Taipei 110, Taiwan., Huang CY; Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University Taipei 100, Taiwan., Yu CC; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital Kaohsiung 813, Taiwan.; Department of Urology, School of Medicine, National Yang-Ming University Taipei 112, Taiwan.; Department of Pharmacy, Tajen University Pingtung 907, Taiwan., Lin VC; Department of Urology, E-Da Hospital Kaohsiung 824, Taiwan.; School of Medicine for International Students, I-Shou University Kaohsiung 840, Taiwan., Geng JH; Department of Urology, Kaohsiung Medical University Hospital Kaohsiung 807, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.; Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital Kaohsiung 812, Taiwan., Li CY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.; Department of Medical Research, Kaohsiung Medical University Hospital Kaohsiung 807, Taiwan., Lu TL; Department of Pharmacy, China Medical University Taichung 406, Taiwan., Bao BY; Department of Pharmacy, China Medical University Taichung 406, Taiwan.; Sex Hormone Research Center, China Medical University Hospital Taichung 404, Taiwan.; Department of Nursing, Asia University Taichung 413, Taiwan.
Source: American journal of cancer research [Am J Cancer Res] 2024 Jan 15; Vol. 14 (1), pp. 169-181. Date of Electronic Publication: 2024 Jan 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2156-6976